Tumour cells intensified the purine salvage pathway to accelerate their growth and proliferation [24] by shifting HPX from the catabolic to the salvage pathway via hypoxanthine-guanine phosphoribosyltransferase (HPRT) enzyme [11] to meet the demand for nucleic acid synthesis [25]. This evidence concerns the gene HPX and neoplasm.